drugset / Trial / NCT01695824
Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to assess combined end point (All stroke, Systemic embolism, Cardiovascular death) between two groups.
Timeline
- Start
- 2011-12
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Warfarin | Small molecule | — | — |